PHOTO
FILE PHOTO: People stand outside the Maiden Pharmaceuticals plant that was sealed by the Indian government officials in 2022, in Sonipat in the northern state of Haryana, India, February 2, 2023. In October 2022, the deaths of more than 70 Gambian children from Acute Kidney Injury were linked by global health officials to cough syrups made in India by Maiden Pharmaceuticals and contaminated with ethylene glycol (EG) and diethylene glycol (DEG). REUTERS/Adnan Abidi/File Photo Image used for illustrative purpose.
India has directed Riemann Labs, a manufacturer linked to cough syrup deaths in Cameroon, to stop manufacturing activities, the country's health ministry said in a statement on Tuesday. (Reporting by Sakshi Dayal, Editing by Louise Heavens)
